THE PHYSIOLOGICAL BREAKDOWN OF THE THIRD COMPONENT OF HUMAN COMPLEMENTHARRISON RA; LACHMANN PJ.1980; MOL. IMMUNOL.; GBR; DA. 1980; VOL. 17; NO 1; PP. 9-20; BIBL. 44 REF.Article

AN IMPROVED PURIFICATION PROCEDURE FOR THE THIRD COMPONENT OF COMPLEMENT AND BETA 1H GLOBULIN FROM HUMAN SERUMHARRISON RA; LACHMANN PJ.1979; MOL. IMMUNOL.; GBR; DA. 1979; VOL. 16; NO 10; PP. 767-776; BIBL. 46 REF.Article

THE FAILURE TO SHOW A NECESSARY ROLE FOR C3 IN THE IN VITRO ANTIBODY RESPONSEWALDMANN H; LACHMANN PJ.1975; EUROP. J. IMMUNOL.; GERM.; DA. 1975; VOL. 5; NO 3; PP. 185-193; BIBL. 40REF.Article

IN VITRO MODULATION OF VIRAL CELL SURFACE GLYCOPROTEINS BY ANTI-VIRAL ANTIBODY IN THE PRESENCE OF COMPLEMENTGORMAN NT; LACHMANN PJ.1982; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1982; VOL. 50; NO 3; PP. 507-514; BIBL. 21 REF.Article

INTESTINAL GLYCOPROTEIN ACTIVATES THE ALTERNATIVE COMPLEMENT PATHWAY BY REACTING WITH FACTOR HWINSNES R; LACHMANN PJ.1982; SCAND. J. IMMUNOL.; ISSN 0300-9475; NOR; DA. 1982; VOL. 15; NO 4; PP. 371-378; BIBL. 20 REF.Article

COMPLEMENT RECEPTORS AND CELL ASSOCIATED COMPLEMENT COMPONENTS.MCCONNELL I; LACHMANN PJ.1977; IMMUNOL. COMMUNIC.; U.S.A.; DA. 1977; VOL. 6; NO 2; PP. 111-132; BIBL. 3 P.Article

ALLOTYPES OF COMPLEMENT COMPONENTS IN MAN.HOBART MJ; LACHMANN PJ.1976; TRANSPLANT. REV.; DENM.; DA. 1976; VOL. 32; PP. 26-42; BIBL. 3 P.Article

REACTION MECHANISM OF THE ALTERNATIVE PATHWAY OF COMPLEMENT FIXATION = MECANISME DE REACTION DE LA VOIE ALTERNEE DE LA FIXATION DU COMPLEMENTLACHMANN PJ; NICOL P.1973; LANCET; G.B.; DA. 1973; NO 7801; PP. 465-467; BIBL. 9REF.Serial Issue

FACTOR B OF THE ALTERNATIVE COMPLEMENT PATHWAY ON HUMAN LYMPHOCYTES.HALBWACHS L; LACHMANN PJ.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 6-7; PP. 697-704; BIBL. 31 REF.Article

THE INFLUENCE OF C3B INACTIVATOR (KAF) CONCENTRATION ON THE ABILITY OF SERUM TO SUPPORT COMPLEMENT ACTIVATIONLACHMANN PJ; HALBWACHS L.1975; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1975; VOL. 21; NO 1; PP. 109-114; BIBL. 10REF.Article

IN VIVO DIMINUTION BY CHELATORS OF SNAKE VENOM-PROVOKED HEMORRHAGE AND IN VITRO INHIBITION OF PROTEOLYTIC ACTIVITYGIROUX E; LACHMANN PJ.1981; TOXICON (OXF.); ISSN 0041-0101; GBR; DA. 1981; VOL. 19; NO 4; PP. 481-492; BIBL. 18 REF.Article

THE DETECTION AND CHARACTERIZATION OF A MEMBRANE PROTEIN WITH FACTOR B-LIKE ACTIVITY ON HUMAN LYMPHOID CELLSWOO P; LACHMANN PJ.1981; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1981; VOL. 44; NO 3; PP. 629-639; BIBL. 12 REF.Article

IGG SYNTHESIS WITHIN THE BRAIN IN MULTIPLE SCLEROSIS AND SUBACUTE SCLEROSING PANENCEPHALITISEWAN PW; LACHMANN PJ.1979; CLIN. EXPER. IMMUNOL.; GBR; DA. 1979; VOL. 35; NO 2; PP. 227-235; BIBL. 1 P.Article

COUPLING PPD TO TUMOUR CELLS ENHANCES THEIR ANTIGENICITY IN BCG-PRIMED MICE.LACHMANN PJ; SIKORA K.1978; NATURE; G.B.; DA. 1978; VOL. 271; NO 5644; PP. 463-464; BIBL. 7 REF.Article

DEMONSTRATION OF T-CELL AND K-CELL CYTOTOXICITY AGAINST MEASLES-INFECTED CELLS IN NORMAL SUBJECTS, MULTIPLE SCLEROSIS AND SUBACUTE SCLEROSING PANENCEPHALITIS.EWAN PW; LACHMANN PJ.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 30; NO 1; PP. 22-31; BIBL. 36 REF.Article

THE FRACTIONATION OF ANTIGEN-DEPENDENT MACROPHAGE MIGRATION INHIBITION AND MACROPHAGE ACTIVATION FACTORS FROM LYMPH DRAINING A TUBERCULIN REACTIONLOWE DM; LACHMANN PJ.1974; SCAND. J. IMMUNOL.; SWED.; DA. 1974; VOL. 3; NO 4; PP. 423-432; BIBL. 20REF.Article

THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION. THE ROLE OF C3 AND ITS INACTIVATOR (KAF)NICOL PAE; LACHMANN PJ.1973; IMMUNOLOGY; G.B.; DA. 1973; VOL. 24; NO 2; PP. 259-275; BIBL. 1 P.1/2Serial Issue

THE HETEROGENIZATION OF TUMOUR CELLS WITH TUBERCULIN. II: STUDIES OF THE ANTIGENICITY OF TUBERCULIN-HETEROGENIZED MURINE TUMOUR CELLS IN SYNGENEIC BCG POSITIVE AND BCG NEGATIVE MICEVYAKARNAM A; LACHMANN PJ; SIKORA K et al.1981; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1981; VOL. 42; NO 2; PP. 337-348; BIBL. 1 P.Article

INTRACEREBRAL SYNTHESIS OF ANTIBODIES TO MEASLES AND DISTEMPER VIRUSES IN PATIENTS WITH SUBACUTE SCLEROSING PANENCEPHALITIS AND MULTIPLE SCLEROSISGORMAN NT; HABITCH J; LACHMANN PJ et al.1980; CLIN. EXPER. IMMUNOL.; GBR; DA. 1980; VOL. 39; NO 1; PP. 44-52; BIBL. 41 REF.Article

INHERITED STRUCTURAL VARIATION AND LINKAGE RELATIONSHIPS OF C7.HOBART MJ; JOYSEY V; LACHMANN PJ et al.1978; J. IMMUNOGENET.; GBR; DA. 1978; VOL. 5; NO 3; PP. 157-163; BIBL. 2 P.Article

A MECHANISM OF MIGRATION INHIBITION INVOLVING COMPONENTS OF THE COAGULATION SYSTEM.MEADE CJ; LACHMANN PJ; BINNS RM et al.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 5; PP. 529-539; BIBL. 43 REF.Article

POLYMORPHISM OF HUMAN C5HOBART MJ; VAZ GUEDES MA; LACHMANN PJ et al.1981; ANN. HUM. GENET.; ISSN 0003-4800; GBR; DA. 1981; VOL. 45; NO 1; PP. 1-4; BIBL. 3 REF.Article

THE COAGGLUTINATION PHENOMENON OF BORDET AND GENGOU INVOLVES A REACTION BETWEEN ANTIBODY-AGGREGATED FOURTH COMPONENT OF COMPLEMENT AND A RECEPTOR ON GUINEA PIG RED CELLSCOOMBS RRA; WILSON AB; LACHMANN PJ et al.1980; INTERNATION. ARCH. ALLERGY APPL. IMMUNOL.; CHE; DA. 1980; VOL. 61; NO 4; PP. 371-379; BIBL. 9 REF.Article

IN VITRO COMPLEMENT ACTIVATION BY RABBIT LYMPHOCYTES AND THYMOCYTES IN AUTOLOGOUS SERUMWILSON AB; LACHMANN PJ; COOMBS RRA et al.1979; IMMUNOLOGY; GBR; DA. 1979; VOL. 37; NO 1; PP. 25-34; BIBL. 21 REF.Article

C6: SYNTHESIS BY THE LIVER IN VIVO.HOBART MJ; LACHMANN PJ; CALNER RY et al.1977; J. EXPER. MED.; U.S.A.; DA. 1977; VOL. 146; NO 2; PP. 629-630; BIBL. 5 REF.Article